News
MicroPort CardioFlow Announces First Series of AnchorMan™ LAAC System Implantations in Italy - 17 Jun 2026
MicroPort CardioFlow has announced the successful first series of impl...MicroPort CardioFlow Appoints Hugues Gervais as Chief Commercial Officer - 08 Jun 2026
Mr. Gervais is a seasoned international executive with more than 25 ye...MicroPort CardioFlow Announces Commercial Launch of LBBOT Solution(1) in Europe and Australia - 01 Jun 2026
MicroPort CardioFlow has commercially launched LBBOT Solution¹ in Euro...MicroPort® Appoints Greg Holman as Chief Commercial Officer - 27 May 2026
Before joining MicroPort®, Mr. Holman held senior leadership roles at ...MicroPort® Endovastec™ Fishhawk™ Mechanical Thrombectomy Device Receives NMPA Approval in China - 14 May 2026
MicroPort® Endovastec™ has received NMPA marketing approval in China f...MicroPort® Endovastec™’s SunFlow™ Drug-Eluting Peripheral Stent System Granted NMPA Green Channel Designation for Innovative Medical Devices - 07 May 2026
MicroPort® Endovastec™ has announced that its SunFlow™ Drug-Eluting Pe...MicroPort® Coronary's Firefighter™ Pro PTCA Balloon Catheter Receives FDA 510(k) Clearance - 15 Apr 2026
Firefighter™ Pro PTCA Balloon Catheter has received 510(k) clearance f...MicroPort EP's PulseMagic™ Pulsed Field Ablation System Receives EU CE MDR Certification and Makes European Market Debut - 14 Apr 2026
MicroPort EP has received EU MDR CE certification for its PulseMagic™ ...MicroPort® Coronary Receives CE MDR Certification for Three Coronary Intervention Products - 06 Apr 2026
MicroPort® Coronary, a subsidiary of MicroPort Scientific Corporation,...MicroPort® Coronary’s Firehawk® Stent Marks Entry into Sub-Saharan Africa with First Commercial Implantation in Kenya - 06 Apr 2026
The official entry of MicroPort® Coronary products into the Sub-Sahara...APOLLO Dream® Sirolimus Target Eluting Stent System Granted FDA Breakthrough Device Designation - 31 Mar 2026
Intracranial atherosclerotic disease (ICAD) is a leading cause of isch...MicroPort® Endovastec™’s HawkMaster™ Detachable Fibered Embolization Coils Receive Marketing Approval in China - 23 Mar 2026
MicroPort® Endovastec™ has received NMPA marketing approval in China f...FDA Grants Breakthrough Device Designation to Endovastec™’s Hector™ Multi-Branch Thoracic Stent Graft System - 13 Mar 2026
United States Food and Drug Administration (FDA) has granted Breakthro...Toumai® Laparoscopic Surgical Robot Surpasses 200 Global Commercial Orders - 02 Mar 2026
Toumai® laparoscopic surgical robot has surpassed 200 global commercia...MicroPort CardioFlow Announces Commercial Launch of FLEXIGO™ 3D delivery system for LBBAP in Europe and Australia - 10 Feb 2026
MicroPort CardioFlow has announced the commercial launch of the FLEXIG...TARGET-FIRST Trial Named Among Top 10 Interventional Cardiology Papers of 2025 by European Heart Journal - 05 Feb 2026
The TARGET-FIRST trial, evaluating a simplified antiplatelet strategy ...